Takeda Inks Deal To Develop Anti-Obesity Drugs With LG Life Sciences
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement is one of three announced by Takeda March 30, including a deal to develop cancer compounds with CanBas.